leukemia/albumin

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 25 rezilta yo

Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

This study is a double blind, randomized control trial (RCT). This study will be concluded in 2 months, from May to July 2020, from subject selection to the end of follow up. Research subjects are obtained consecutively from Covid-19 patients who receive care in the intensive care unit (ICU) across

Correlation of Polymorphisms of Lipoprotein Lipase (LpL) and Apolipoprotein E (Apo E) With Lipid Profile of Children With Acute Lymphoblastic Eukaemia During Therapy With L - Asparaginase.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Introduction Malignancies during childhood constitute the 2nd cause of death, following injuries worldwide. According to epidemiological data, 300,000 new cases of neoplasia present themselves every year in children and teenagers under 19 years of age1, 160,000 of which concern children under the

Cooking Education and Adapted Physical Activity in Allografted Patients

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Bone marrow transplantation is the main strategy to cure leukemia and others hematopoietic malignancies. It includes a first step of chemotherapy during several days (combined sometimes to radiotherapy), a second step of stem cells infusion and a third step of management of complications during

CD4CAR for CD4+ Leukemia and Lymphoma

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The study will be performed as a dose-escalation protocol. Due to the relatively low incidence and prevalence of cluster of differentiation 4-positive (CD4+) hematological malignancies and the associated aggressive nature of these diseases and the sequel of treatment failure, the investigators

Hematotoxicity in Acute Lymphoblastic Leukemia Children in Maintenance Phase Therapy

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

All medical record data of LLA child patient at maintenance phase therapy, who came to Cipto Mangunkusumo Kiara Hospital in period 2014 - 2016. the data that are colected consist of age, gender, disease stratification, nutritional status, the dosage of 6-MP, albumin levels, hemoglobin levels,

Hematotoxicity in Maintenance Therapy of Children With Acute Lymphoblastic Leukemia

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

On the day of the control patient, (usually the patient is asked for routine control at week 3 on mercaptopurin) routine blood tests are performed. Patients and parents were given an explanation of this study. If patients and parents are willing to take part in the study, they are asked to sign

The British Osteonecrosis Study

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Children, teenagers or young adults between the age of 10 (including the day of the 10th birthday) and 24 years 364 days (at the time of diagnosis) with a first diagnosis of acute lymphoblastic leukaemia or lymphoblastic lymphoma (T-NHL or SmIg negative precursor B-NHL) diagnosed under standard

Faecal Microbiota Transplantation in Irritable Bowel Syndrome

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

1. Background Irritable bowel syndrome (IBS) is a chronic, debilitating, functional gastrointestinal disorder with estimated population prevalence in Europe between of 10 -15% (Ford et al). These symptoms can be debilitating and lead to a significant reduction in quality of life particularly in the

BMT Autologous MSCs for GvHD

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

EPIC MSC2014-002 solution- Autologous Mesenchymal Stromal Cells expanded using pooled human platelet lysate,is made up of autologous marrow-derived mesenchymal stromal cells ex vivo expanded numerically for approximately 14 days using pooled human Platelet Lysate (phPL), harvested from culture on

Long-term Use of Romidepsin in Patients With CTCL

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

This project is a retrospective and prospective chart review of patients who present at Northwestern Medical Faculty Foundation clinic with the diagnosis of CTCL. It includes Mycosis Fungoid, Sézary Syndrome and other subtypes of CTCL, like Cytotoxic Cutaneous T-cell lymphomas. Those patients that

Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

AIMS AND OBJECTIVES: - To study GH-IGF1 axis in children with CML having short stature following Imatinib therapy. - To administer growth hormone therapy to children with CML on Imatinib in remission having GH deficiency. STUDY DESIGN: It is an interventional, non-randomized study. STUDY GROUP: one

TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy and Tolerability. The TIKlet Study

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

1. Patients 1.1. Patients CML patients will be included according to the following inclusion criteria: a) patients of both sexes, b) age between 18 and 80 years, c) treated with imatinib or nilotinib, d) included in the follow-up in the Divisions / Units of Hematology involved in the project e) able

Phase II Study of Decitabine and Cytarabine for Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Study Groups: If you are found to be eligible to take part in this study, you will be assigned to a study group based on when you join this study. The first group of 10 participants to join the study will be enrolled in the Pilot portion of the study. The next group of up to 40 participants will be

Steroid Treatment of Idiopathic Nephrotic Syndrome

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Background Idiopathic nephrotic syndrome (INS) is the most frequent glomerular disease in childhood, with an incidence of 2-4 cases per 100,000 children. Currently, all children with INS are treated at onset with steroids. Approximately 80% of cases respond to oral corticosteroid therapy, but 75-80%

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye